Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03850093Phase 4Completed
Phase 4, randomised, double-blind trial of gabapentin in chronic rhinosinusitis (CRS) (3 arms), sponsored by Zagazig University. Primary endpoints: Changes in Surgical Field Visibility and Intraoperative Blood Loss. Started Aug 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03850093.